IMPLANT SITE CALCIFICATION

IMPLANT SITE CALCIFICATION was reported 23 times

IMPLANT SITE CALCIFICATION is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 gamma-Aminobutyric Acid-ergic Agonist [EPC] 7 0.0001
1 Parathyroid Hormone Analog [EPC] 1 0.0000
2 Sulfonylurea [EPC] 1 0.0000
3 Angiotensin Converting Enzyme Inhibitor [EPC] 1 0.0000
4 Calcium [EPC] 1 0.0000
5 Phosphodiesterase 4 Inhibitor [EPC] 1 0.0000
6 Thiazide Diuretic [EPC] 1 0.0000
7 Nucleoside Metabolic Inhibitor [EPC] 1 0.0000
8 Progestin [EPC] 1 0.0000
9 Insulin Analog [EPC] 1 0.0000
10 Benzodiazepine [EPC] 1 0.0000
11 Tumor Necrosis Factor Blocker [EPC] 1 0.0000